Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3031 AL 3045

Role of reactive oxygen species in the progression of Alzheimer's disease

Bhatt S, Puli L, Patil CR.

Drug Discov Today. 2021 Mar;26(3):794-803. doi: 10.1016/j.drudis.2020.12.004. Epub 2020 Dec 8.

Galantamine beyond Alzheimer's disease-a fact or artefact?

Naguy A, Husain K, Alamiri B.

CNS Spectr. 2022 Jun;27(3):268-271. doi: 10.1017/S1092852920002229. Epub 2020 Dec 14.

Souvenaid for Alzheimer's disease

Burckhardt M, Watzke S, Wienke A, Langer G, Fink A.

Cochrane Database Syst Rev. 2020 Dec 15;12(12):CD011679. doi: 10.1002/14651858.CD011679.pub2.

Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials

Tian Hui Kwan A, Arfaie S, Therriault J, Rosa-Neto P, Gauthier S.

Dement Geriatr Cogn Disord. 2020;49(4):334-348. doi: 10.1159/000511506. Epub 2020 Dec 15.

Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer's Disease

Kang YJ, Diep YN, Tran M, Cho H.

Int J Mol Sci. 2020 Dec 16;21(24):9591. doi: 10.3390/ijms21249591.

Recent Advances in Virtual Screening for Cholinesterase Inhibitors

Miles JA, Ross BP.

ACS Chem Neurosci. 2021 Jan 6;12(1):30-41. doi: 10.1021/acschemneuro.0c00627. Epub 2020 Dec 22.

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer's Diseases

Hepp Rehfeldt SC, Majolo F, Goettert MI, Laufer S.

Int J Mol Sci. 2020 Dec 18;21(24):9677. doi: 10.3390/ijms21249677.

Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review

Gruendler R, Hippe B, Sendula Jengic V, Peterlin B, Haslberger AG.

Molecules. 2020 Dec 18;25(24):6018. doi: 10.3390/molecules25246018.

Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy

Damri O, Shemesh N, Agam G.

Int J Mol Sci. 2020 Dec 27;22(1):189. doi: 10.3390/ijms22010189.

Deep Brain Stimulation for Alzheimer's Disease: Tackling Circuit Dysfunction

Lam J, Lee J, Liu CY, Lozano AM, Lee DJ.

Neuromodulation. 2021 Feb;24(2):171-186. doi: 10.1111/ner.13305. Epub 2020 Dec 30.

Alpiniae oxyphyllae Fructus and Alzheimer's disease: An update and current perspective on this traditional Chinese medicine

Li J, Du Q, Li N, Du S, Sun Z.

Biomed Pharmacother. 2021 Mar;135:111167. doi: 10.1016/j.biopha.2020.111167. Epub 2020 Dec 29.

Alzheimer's Disease: The Unwanted Companion of Elderly

Chawla PA, Parikh V.

CNS Neurol Disord Drug Targets. 2020;19(9):646-647. doi: 10.2174/187152731909201119090829.

Advances in Drug Therapy for Alzheimer's Disease

Zhu CC, Fu SY, Chen YX, Li L, Mao RL, Wang JZ, Liu R, Liu Y, Wang XC.

Curr Med Sci. 2020 Dec;40(6):999-1008. doi: 10.1007/s11596-020-2281-2. Epub 2021 Jan 11.

Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target

Gu JL, Liu F.

Curr Med Sci. 2020 Dec;40(6):1009-1021. doi: 10.1007/s11596-020-2282-1. Epub 2021 Jan 11.

Inflammation in Alzheimer's Disease

Fakhoury M.

Curr Alzheimer Res. 2020;17(11):959-961. doi: 10.2174/156720501711210101110513.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias